176 related articles for article (PubMed ID: 20644954)
1. 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism.
Hennings J; Sundin A; Hägg A; Hellman P
Langenbecks Arch Surg; 2010 Sep; 395(7):963-7. PubMed ID: 20644954
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.
Burton TJ; Mackenzie IS; Balan K; Koo B; Bird N; Soloviev DV; Azizan EA; Aigbirhio F; Gurnell M; Brown MJ
J Clin Endocrinol Metab; 2012 Jan; 97(1):100-9. PubMed ID: 22112805
[TBL] [Abstract][Full Text] [Related]
3. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.
Hennings J; Lindhe O; Bergström M; Långström B; Sundin A; Hellman P
J Clin Endocrinol Metab; 2006 Apr; 91(4):1410-4. PubMed ID: 16403816
[TBL] [Abstract][Full Text] [Related]
4. Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism.
Soinio M; Luukkonen AK; Seppänen M; Kemppainen J; Seppänen J; Pienimäki JP; Leijon H; Vesterinen T; Arola J; Lantto E; Helin S; Tikkanen I; Metso S; Mirtti T; Heiskanen I; Norvio L; Tiikkainen M; Tikkanen T; Sane T; Välimäki M; Gomez-Sanchez CE; Pörsti I; Nuutila P; Nevalainen PI; Matikainen N
Eur J Endocrinol; 2020 Dec; 183(6):539-550. PubMed ID: 33055298
[TBL] [Abstract][Full Text] [Related]
5. Para-chloro-2-[
Silins I; Sundin A; Nordeman P; Jahan M; Estrada S; Monazzam A; Lubberink M; Aigbirhio F; Hellman P; Antoni G
Int J Med Sci; 2021; 18(10):2187-2196. PubMed ID: 33859526
[No Abstract] [Full Text] [Related]
6. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
Hennings J; Hellman P; Ahlström H; Sundin A
Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
[TBL] [Abstract][Full Text] [Related]
7. Masked volume wise Principal Component Analysis of small adrenocortical tumours in dynamic [11C]-metomidate Positron Emission Tomography.
Razifar P; Hennings J; Monazzam A; Hellman P; Långström B; Sundin A
BMC Med Imaging; 2009 Apr; 9():6. PubMed ID: 19386097
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
Zettinig G; Mitterhauser M; Wadsak W; Becherer A; Pirich C; Vierhapper H; Niederle B; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1224-30. PubMed ID: 15197504
[TBL] [Abstract][Full Text] [Related]
9. Predicting Treatment Response in Primary Aldosteronism Using 11 C-Metomidate Positron Emission Tomography.
Lu CC; Chen CJ; Peng KY; Chueh JS; Chang CC; Yen RF; Wu VC;
Clin Nucl Med; 2022 Nov; 47(11):936-942. PubMed ID: 36215396
[TBL] [Abstract][Full Text] [Related]
10. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
Minn H; Salonen A; Friberg J; Roivainen A; Viljanen T; Långsjö J; Salmi J; Välimäki M; Någren K; Nuutila P
J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
[TBL] [Abstract][Full Text] [Related]
11.
O'Shea PM; O'Donoghue D; Bashari W; Senanayake R; Joyce MB; Powlson AS; Browne D; O'Sullivan GJ; Cheow H; Mendichovszky I; Quill D; Lowery A; Lappin D; Gurnell M; Dennedy MC
Clin Endocrinol (Oxf); 2019 May; 90(5):670-679. PubMed ID: 30721535
[TBL] [Abstract][Full Text] [Related]
12. Lateralization in
Isojärvi J; Viukari M; Pörsti I; Leijon H; Vesterinen T; Seppänen M; Nevalainen PI; Matikainen N
Endocrinol Diabetes Metab; 2022 Nov; 5(6):e368. PubMed ID: 36039035
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of benign adrenocortical adenomas with 18F-FDG PET accumulation.
Ishiwata K; Suzuki S; Igarashi K; Ruike Y; Naito K; Ishida A; Deguchi-Horiuchi H; Fujimoto M; Koide H; Imamura Y; Sakamoto S; Ichikawa T; Ikeda JI; Yokote K
Eur J Endocrinol; 2021 Jun; 185(1):155-165. PubMed ID: 33960957
[TBL] [Abstract][Full Text] [Related]
14.
Chen Cardenas SM; Santhanam P
Endocrine; 2020 Dec; 70(3):479-487. PubMed ID: 32886316
[TBL] [Abstract][Full Text] [Related]
15. Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism.
Shapiro B; Grekin R; Gross MD; Freitas JE
Clin Nucl Med; 1994 May; 19(5):441-5. PubMed ID: 8039321
[TBL] [Abstract][Full Text] [Related]
16. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.
Bergström M; Juhlin C; Bonasera TA; Sundin A; Rastad J; Akerström G; Långström B
J Nucl Med; 2000 Feb; 41(2):275-82. PubMed ID: 10688111
[TBL] [Abstract][Full Text] [Related]
17. Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET/CT.
Watanabe H; Kanematsu M; Goshima S; Kondo H; Kawada H; Noda Y; Moriyama N
Ann Nucl Med; 2013 Aug; 27(7):648-53. PubMed ID: 23625579
[TBL] [Abstract][Full Text] [Related]
18. Nuclear imaging in the diagnosis of primary aldosteronism.
Powlson AS; Gurnell M; Brown MJ
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):150-6. PubMed ID: 25871964
[TBL] [Abstract][Full Text] [Related]
19. First-in-human evaluation of [
Silins I; Sundin A; Lubberink M; O'Sullivan L; Gurnell M; Aigbirhio F; Brown M; Wall A; Åkerström T; Roslin S; Hellman P; Antoni G
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):398-409. PubMed ID: 36074157
[TBL] [Abstract][Full Text] [Related]
20. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
